ADIPOQ and Alzheimer disease: No significant differences were found between circulating ADPN and AD risk by analyzing the FinnGen consortium GWAS database in the IVW method [odds ratio (OR): 0.874, 95% CI: 0.701–1.089, p = 0.230].